APPB — Applied Biosciences Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.45m
- $0.71m
Annual income statement for Applied Biosciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.046 | 0.198 | 0.707 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.039 | 0.042 | 0.185 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.017 | 0.028 | 0.561 | 2.58 | 3.35 |
| Operating Profit | -0.017 | -0.028 | -0.516 | -2.39 | -2.65 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.017 | -0.028 | -0.516 | -2.39 | -2.68 |
| Net Income After Taxes | -0.017 | -0.028 | -0.516 | -2.39 | -2.68 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.017 | -0.028 | -0.518 | -2.38 | -2.63 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.017 | -0.028 | -0.518 | -2.38 | -2.63 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.022 | -0.001 | -0.012 | -0.098 | -0.221 |
| Dividends per Share |